C3.ai Inc vs ResMed Inc. — how do they compare? C3.ai Inc trades at $10.53 (market cap $1.65B), while ResMed Inc. trades at $220 (market cap $32.61B). The key difference: ResMed Inc. is far larger — about 19.8× C3.ai Inc's market cap, and ResMed Inc. pays a 1.17% dividend while C3.ai Inc pays none. Which is the better fit depends on your goals.
| AI | RMD | |
|---|---|---|
Market Cap | $1.65B | $32.61B |
Sector | Technology | Health |
52-Week High | $19.66 | $293.73 |
52-Week Low | $7.76 | $182.82 |
Enterprise Value | $1.08B | $31.97B |
Dividend Yield | — | 1.17% |
Trailing returns across standard periods
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Suite, is a comprehensive application development and runtime environment that is designed to allow customers to rapidly design, develop, and deploy Enterprise AI applications of any type
Read more on AI →ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →